Influence of Liver Fibrosis on Highly Active Antiretroviral Therapy--Associated Hepatotoxicity in Patients with HIV and Hepatitis C Virus Coinfection
L. Aranzabal, J. L. Casado, J. Moya, C. Quereda, S. Diz, A. Moreno, L. Moreno, A. Antela, M. J. Perez-Elias, F. Dronda, A. Marin, F. Hernandez-Ranz
(+2 others)
A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2018; you can also visit the original URL.
The file type is application/pdf.
L. Aranzabal, J. L. Casado, J. Moya, C. Quereda, S. Diz, A. Moreno, L. Moreno, A. Antela, M. J. Perez-Elias, F. Dronda, A. Marin, F. Hernandez-Ranz, A. Moreno, S. Moreno. "Influence of Liver Fibrosis on Highly Active Antiretroviral Therapy--Associated Hepatotoxicity in Patients with HIV and Hepatitis C Virus Coinfection." Clinical Infectious Diseases 40.4 (2005) 588-593